-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Srixon Announces Buy 2, Get 1 Free Golf Ball Promotion
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
-
Who Is the Best Spanish-Speaking Private Investigator in Sacramento?
-
Healixa Turns Patents Into Products: FrostPulse(TM) Delivered and Five Eternal Spring(TM) Units Enter Production
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Cosmos Health Reports Record Nine-Month Revenue of $53.6 Million, Up 18%; Q3 Gross Margin Up 465 Basis Points Sequentially; Total Debt Down 34% and Stockholders' Equity Up 21% Since Year-End
-
Nearly Half of Transformation Initiatives Face a 'Momentum Gap' That Puts Value at Risk, NSP & Company Study Finds
-
CXAI Expands Agentic AI Reach into Mid-Market Through EngineRoom's Simpro Partnership
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Agency Guacamole's 10th B.L.N.D. Event Brought Industry Leaders Together for a Conversation on the Evolution of Diversity and Inclusion in Beauty
-
From Pilot to Production: InHand Networks' Practical Approach to Industrial Edge AI
WHO eyes 'encouraging' signs in DRCongo fight against Ebola
The Ebola epidemic in the Democratic Republic of Congo is still spreading but appears to be showing "encouraging" signs of improvement, the head of the World Health Organization said on Wednesday.
"We are starting to see encouraging signs that we're gaining ground," Tedros Adhanom Ghebreyesus told a news conference in Geneva.
Since the DRC declared its 17th Ebola outbreak in mid-May, more than 3,500 deaths have been recorded from over 7,200 cases to date across seven northern and eastern provinces plagued by widespread insecurity and a litany of armed groups.
Ebola, which is transmitted through contact with bodily fluids and can cause severe internal and external bleeding and organ failure, has killed more than 15,000 people in Africa over the last 50 years.
Tedros said that transmission was declining in the worst-affected areas of Ituri province, the epicentre of the outbreak, while South Kivu has not reported any new cases since May.
"Trials of treatments and post-exposure prophylaxis are picking up speed, due to increased community engagement," he added.
"Vaccine trials should begin in the coming weeks," Tedros said, while warning against complacency. "Make no mistake: the epidemic continues to grow and continues to kill," he said.
"We still have many, many months ahead of us," added Maria Van Kerkhove, director of epidemic and pandemic management at the UN health agency.
- Right response -
In North Kivu, the number of cases was rising "fast", Tedros said, with weekly cases almost doubling from about 100 to more than 200.
"The area is so vast that it is hard to speak of a single epidemic. It is many outbreaks, in many places. We must get the response right in every one of them," he added.
The remoteness of the province, high population mobility and attacks on humanitarian workers were further complicating efforts to fight the epidemic, he explained.
The Africa Centres for Disease Control and Prevention (CDC) and the WHO issued a funding appeal in June for $518 million to support the epidemic response until November.
Both organisations and the Congolese government earlier this month launched a new bid for $1.3 billion for the next six months, on top of the $1.1 billion requested by the UN in August for humanitarian assistance, WHO health emergencies chief Chikwe Ihekweazu said.
There is currently no approved vaccine or treatment against the Bundibugyo strain responsible for the current outbreak.
Some 70,000 doses of the Ervebo vaccine, which has been approved against the Zaire strain of Ebola, have been sent to the DRC to assess its effects on tackling the spread of Bundibugyo.
More than 3,000 health workers and frontline staff have already been vaccinated in Kisangani, said Meg Doherty, director of science for health at the UN health agency.
An observational study led by the Doctors Without Borders (MSF) charity will start on Saturday to evaluate the vaccine's effectiveness in reducing illness and death, she added.
Clinical trials of two vaccines in development against Bundibugyo will take place in the country on a date to be fixed.
Th.Gonzalez--AT